HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lamblin, C. Articles by Wallaert, B. Search for Related Content PubMed PubMed Citation Articles by Lamblin, C. Articles by Wallaert, B.

Interstitial lung diseases in collagen vascular diseases

Pneumonology Dept, Calmette Hospital, CHRU and INSERM U 416, Pasteur Institute, Lille, France

CORRESPONDENCE: B. Wallaert, Clinique des Maladies Respiratoires, Service de Pneumologie et Immuno-allergologie, Hopital A. Calmette, 59037, LILLE cedex, France. Fax: 33 320445768

Keywords: collagen vascular diseases, fibrosis, lung, polymyositis, rheumatoid arthritis, scleroderma

Received: March 8, 2001
In this review, a clinical update is presented of the most important collagen vascular diseases (CVDs) and the different types of interstitial lung disease (ILD) encountered in these CVDs. These CVDs represent a heterogenous group of immunologically mediated inflammatory disorders with a large variety of affected organs besides the lungs.

The frequency, clinical presentation, prognosis and response to therapy vary depending on the histological pattern (usual interstitial pneumonia, desquamative interstitial pneumonia, organising pneumonia, diffuse alveolar damage, nodular lesions, etc.), as well as on the underlying CVD (scleroderma, rheumatoid arthritis, systemic lupus erythematosus, dermatopolymyositis, Sjögren's syndrome or mixed connective tissue disease).

The diagnosis of most of these CVDs is based on a number of criteria; in several of these, however, lung involvement is not part of the diagnostic criteria. In addition, there may be overlaps between several of these CVDs.

Optimal treatment varies depending on the type of collagen vascular disease and the presence of interstitial lung disease, although in many cases, a combination of corticosteroids and cytostatic drugs are given.

This article has been cited by other articles:

				R. Kim and K. C. Meyer Review: Therapies for interstitial lung disease: past, present and future Therapeutic Advances in Respiratory Disease, October 1, 2008; 2(5): 319 - 338. [Abstract] [PDF]